Physician profile
Jenny A Johnson
NPI 1568082055
$1,808.03
in general payments reported to CMS, 2019-2025
10 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2022: $450 · 2023: $373 · 2024: $252 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $577.02 | 2021-2025 | Dupixent |
| Optinose US, INC. | $392.43 | 2021-2024 | |
| Genzyme Corporation | $370.02 | 2021-2025 | |
| Inspire Medical Systems, INC. | $206.50 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $66.63 | 2022-2025 | Nucala |
| Alk-Abello, INC | $57.32 | 2021-2025 | Neffy, Odactra, Grastek |
| Karl Storz Endoscopy-America | $51.03 | 2023-2025 | Hopkins |
| Stryker Corporation | $43.95 | 2021-2025 | Core |
| Ge Healthcare | $25.76 | 2025 | |
| Paratek Pharmaceuticals, INC. | $17.37 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.